Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week

What: Corcept Therapeutics zoomed nearly **9%** higher this week.
Why: The biotech company saw a historic stretch of time with positive news.
Signal: The stock's surge indicates growing investor confidence in the company's prospects.
Target: The company's focus on developing new treatments for endocrine disorders has attracted significant attention.
Risk: However, the biotech sector remains highly volatile, and investors should be cautious of potential market fluctuations.